Study outline | Design | Results |
---|---|---|
Tissue thickness | NSCLC and HNSCC tissues sectioned at various thicknesses (3, 4, 5, 6, and 7 μm) | Antibody demonstrated appropriate staining across all thicknesses tested and was representative of clinical PD-L1 status for each case |
Tissue fixation | Tonsil cases processed in 10Â % NBF, zinc formalin, 95Â % alcohol, AFA, Z5 and Prefer with multiple timepoints (1, 6, 12, 24, and 72Â h) in each fixative | Timepoints (6, 12, 24, and 72Â h) in 10Â % NBF, zinc formalin and Z5 were acceptable; 95Â % alcohol, AFA and Prefer were not acceptable |
Ischemia | KARPASS 299 xenograft tissues with multiple cold ischemia times (0, 0.5, 1, 2, 6, and 24Â h) | No significant change in staining intensity from time 0 to hour 24 |
Cut-slide stability | Four tissue samples; cut at 4 μm and stored at 2–8 and 30 °C. Stained at the Day 0 timepoint and at Day 3 and 14 and monthly Month 1 to 12 timepoints | Staining results at different storage temperatures and at timepoints Day 3 and 14, and Months 1 to 12 consistent with results achieved on Day 0 |